Philip L. McCarthy

Roswell Park Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma”.

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

New England Journal of Medicine(2022)10.1056/nejmoa2204925

N/A

6.2DataRank · unranked

474 citations

Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje +51 more

Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

Nature Medicine(2023)10.1038/s41591-022-02128-z

N/A

5.6DataRank · unranked

197 citations

Brian A. Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L. Johnson, Anthony J. Olszanski +39 more

A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202)

American Journal of Hematology(2021)10.1002/ajh.26361

N/A

0.994DataRank · unranked

23 citations

Vera J. Suman, Sascha A. Tuchman, Jacob P. Laubach, Hani Hassoun, Yvonne A. Efebera +7 more

Alliance A061202: ixazomib, pomalidomide, and dexamethasone for patients with lenalidomide-refractory MM in first relapse

Blood Advances(2024)10.1182/bloodadvances.2024013623

N/A

0.372DataRank · unranked

5 citations

Vera J. Suman, Yvonne A. Efebera, Noopur Raje, Sascha A. Tuchman, Cesar Rodriguez Valdes +7 more

Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple Myeloma

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.03.028

N/A

0.351DataRank · unranked

6 citations

Vera J. Suman, Kouros Owzar, Katelyn Santo, Don M. Benson, Thomas C. Shea +10 more

Novel genetic variants associated with mortality after unrelated donor allogeneic hematopoietic cell transplantation

EClinicalMedicine(2021)10.1016/j.eclinm.2021.101093

N/A

0DataRank · unranked

12 citations

Junke Wang, Leah Preus, Ezgi Karaesmen, Abbas Rizvi, Alyssa Clay‐Gilmour +17 more

Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia

Scientific Reports(2021)10.1038/s41598-021-94539-0

N/A

0DataRank · unranked

6 citations

Weiyin Zhou, Lisa J. McReynolds, Hormuzd A. Katki, Elizabeth A. Griffiths, Swapna Thota +23 more

Comparing thermal stress reduction strategies that influence MDSC accumulation in tumor bearing mice

Cellular Immunology(2021)10.1016/j.cellimm.2021.104285

N/A

0DataRank · unranked

16 citations

Samuel Ministero, Manu Pandey, Denisha Robinson, Evan Forti Hong, Bonnie L. Hylander +5 more

Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post–unrelated HCT

Blood Advances(2021)10.1182/bloodadvances.2020003366

N/A

0DataRank · unranked

6 citations

Weiyin Zhou, Junke Wang, Ezgi Karaesmen, Hancong Tang, Philip L. McCarthy +20 more

The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.027

N/A

0DataRank · unranked

3 citations

Nizar J. Bahlis, P. Leif Bergsagel, Manisha Bhutani, Niccolò Bolli, Carrie Brownstein +18 more

The results of multicenter phase II, double-blind placebo-controlled trial of maintenance ixazomib after allogeneic hematopoietic cell transplantation (alloHCT) for high-risk multiple myeloma (MM) from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 1302).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7003

N/A

0DataRank · unranked

2 citations

Qaiser Bashir, Marcelo C. Pasquini, Michael J. Martens, Juan Wu, Melissa Alsina +11 more

Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma

Nature Communications(2022)10.1038/s41467-022-28266-z

N/A

0DataRank · unranked

69 citations

Almuth Maria Anni Merz, Jie Wang, Lei Wei, Qiang Hu, Nicholas Hutson +19 more

Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee

Blood Cancer Journal(2022)10.1038/s41408-022-00695-5

N/A

0DataRank · unranked

61 citations

Lawrence Baizer, Natalie S. Callander, Sergio Giralt, Jens Hillengaß, Boris Freidlin +11 more

Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma

American Journal of Hematology(2022)10.1002/ajh.26596

N/A

0DataRank · unranked

30 citations

Ruta Brazauskas, Edward A. Stadtmauer, Marcelo C. Pasquini, Parameswaran Hari, Asad Bashey +16 more

Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT

Blood Advances(2022)10.1182/bloodadvances.2022008863

N/A

0DataRank · unranked

10 citations

Othmane Jadi, Sarah Dexheimer, Dante S. Bortone, Steven Vensko, Sarah Bennett +19 more

A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.07.007

N/A

0DataRank · unranked

9 citations

T Nishihori, Marcelo C. Pasquini, Michael J. Martens, Juan Wu, Melissa Alsina +15 more

Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.019

N/A

0DataRank · unranked

1 citations

Fotis Asimakopoulos, Abdel Kareem Azab, Giada Bianchi, Manisha Bhutani, Leslie Crews +18 more

Shared Graft Versus Leukemia Minor Histocompatibility Antigens in DISCOVeRY-BMT

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.12.503667

N/A

0DataRank · unranked

1 citations

Othmane Jadi, Sarah Dexheimer, Dante S. Bortone, Steven Vensko, Sarah Bennett +19 more

Associations of Minor Histocompatibility Antigens with Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.31.506092

N/A

0DataRank · unranked

0 citations

Hancong Tang, Kelly Olsen, Steven Vensko, Qianqian Zhu, Yiwen Wang +13 more

A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help

Blood Advances(2023)10.1182/bloodadvances.2023010401

N/A

0DataRank · unranked

12 citations

Sarah Nikiforow, Carlos Bachier, Yen‐Michael S. Hsu, David G. Maloney, Marcela V. Maus +9 more

Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation

Cell Reports(2023)10.1016/j.celrep.2023.112250

N/A

0DataRank · unranked

10 citations

Takemasa Tsuji, Cameron R. MacDonald, Joseph L. Sarow, Hanna R. Rosenheck, Saeed Daneshmandi +10 more

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study

Bone Marrow Transplantation(2023)10.1038/s41409-023-02168-0

N/A

0DataRank · unranked

9 citations

Kristopher Attwood, Xiaojun Liu, George L. Chen, Hans Minderman, Amin M. Alousi +16 more

Pathogenic and likely pathogenic germline variation in patients with myeloid malignancies and their unrelated HLA-matched hematopoietic stem cell donors

Journal of Translational Genetics and Genomics(2024)10.20517/jtgg.2023.31

N/A

0DataRank · unranked

2 citations

J. N. Cooper, Junke Wang, Qianqian Zhu, Loreall Pooler, Xin Sheng +9 more

Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma

Blood(2025)10.1182/blood.2025028963

N/A

0DataRank · unranked

8 citations

Qi Yan, Saeed Daneshmandi, Romain Lannes, Eriko Katsuta, Jee Eun Choi +14 more

β2-Adrenergic receptor activation on donor cells ameliorates acute GvHD

JCI Insight(2020)10.1172/jci.insight.137788

N/A

0DataRank · unranked

18 citations

Joseph L. Sarow, Cameron R. MacDonald, George L. Chen, Jingxin Qiu, Umesh C. Sharma +7 more

Association and Prognostic Significance of Comorbidities in Individuals With MGUS

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.08.019

N/A

0DataRank · unranked

1 citations

Nour Nassour, Malak Alharbi, Alan D. Hutson, Sarah Parker, Joseph D. Tario +6 more

CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab

Cytometry Part B Clinical Cytometry(2020)10.1002/cyto.b.21961

N/A

0DataRank · unranked

45 citations

Joseph D. Tario, Theresa Hahn, Jens Hillengaß, Philip L. McCarthy, Paul K. Wallace +1 more

Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.06.011

N/A

0DataRank · unranked

6 citations

Alan Howard, David Avigan, Manisha Bhutani, Adam D. Cohen, Luciano J. Costa +22 more

Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8506

N/A

0DataRank · unranked

102 citations

Marcelo C. Pasquini, Edward A. Stadtmauer, Raphael Fraser, Mingwei Fei, Steven M. Devine +14 more

β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME

Cell Reports(2021)10.1016/j.celrep.2021.109883

N/A

0DataRank · unranked

136 citations

Cameron R. MacDonald, Philip L. McCarthy, Scott I. Abrams, Elizabeth A. Repasky, Hemn Mohammadpour